UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
Filed by the Registrant þ Filed by a Party other than the Registrant o
Check the appropriate box:
o Preliminary Proxy Statement
o Confidential, For Use of the Commission Only (As Permitted by Rule 14a-6(e)(2))
o Definitive Proxy Statement
þ Definitive Additional Materials
o Soliciting Material under Rule 14a-12
|
| (Name of Registrant as Specified In Its Charter) |
|
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) |
Payment of Filing Fee (Check the appropriate box):
þ No fee required
o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
(1) Title of each class of securities to which transaction applies:
(2) Aggregate number of securities to which transaction applies:
(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
(4) Proposed maximum aggregate value of transaction:
(5) Total fee paid:
o Fee paid previously with preliminary materials.
o Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.
(1) Amount Previously Paid:
(2) Form, Schedule or Registration Statement No.:
(3) Filing Party:
(4) Date Filed:
ALLIQUA, INC.
2150 Cabot Boulevard West
Langhorne, Pennsylvania
Telephone: (215) 702-8550
September 19, 2013
Dear Shareholder:
The Board of Directors (the “Board”) of Alliqua. Inc. has been conducting a consent solicitation campaign to obtain shareholder approval for an amendment to our articles of incorporation to increase the number of authorized shares of our common stock from 500,000,000 to 2,000,000,000 (the “Proposal”).
The Board has received a favorable response from the shareholders who have submitted their consent. However, significant additional participation is necessary to approve the Proposal as the holders of less than 50% of the outstanding shares of common stock have responded. As such, the Board has extended the consent solicitation period until October 1, 2013 in order to solicit additional consents to the Proposal.
The Board recommends that you submit a written consent “FOR” the Proposal.
* * * * *
Returning your written consent is easy and takes only a few moments of your time. Choose one of the following methods:
1. Return your consent by mail. You may submit your written consent by completing, dating, and signing the written consent form that was mailed to you on or about August 29, 2013 and returning it in the reply envelope that was enclosed.
2. Return your consent via fax. You may submit your written consent by completing, dating, and signing the written consent form that was mailed to you on or about August 29, 2013 and returning it by fax to 202-521-3464.
3. Consent online. You may submit your consent online at https://www.iproxydirect.com/ALQA.
4. Consent by phone. You may submit your consent by phone at 1-866-752-VOTE (8683).
Your consent is important no matter how many shares you own. Please return your consent immediately to be sure your consent is received by October 1, 2013.
Thank you for your participation and your support of our company.
Sincerely,
/s/ David I. Johnson
David I. Johnson
Chief Executive Officer
